Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells

BACKGROUND: A major obstacle in the use of retinoid therapy in cancer is the resistance to this agent in tumors. Retinoic acid facilitates the growth of mammary carcinoma cells which express high levels of fatty acid-binding protein 5 (FABP5). This protein delivers retinoic acid to peroxisome prolif...

Descripción completa

Detalles Bibliográficos
Autores principales: Thulasiraman, Padmamalini, McAndrews, Daniel J, Mohiudddin, Imran Q
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192446/
https://www.ncbi.nlm.nih.gov/pubmed/25260874
http://dx.doi.org/10.1186/1471-2407-14-724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192446/
https://www.ncbi.nlm.nih.gov/pubmed/25260874
http://dx.doi.org/10.1186/1471-2407-14-724

Ejemplares similares